z-logo
open-access-imgOpen Access
Prospective Investigation of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Community-Associated Methicillin-Resistant Staphylococcus aureus Infections
Author(s) -
Loren G. Miller,
Jennifer Tan,
Samantha J. Eells,
Esther Benitez,
Allen B. Radner
Publication year - 2011
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01608-10
Subject(s) - mupirocin , hexachlorophene , medicine , staphylococcus aureus , staphylococcal skin infections , antibiotics , regimen , skin infection , methicillin resistant staphylococcus aureus , staphylococcal infections , micrococcaceae , prospective cohort study , microbiology and biotechnology , antibacterial agent , biology , chemistry , organic chemistry , bacteria , genetics
Recurrent community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections are an increasingly common problem. However, there are no data on the efficacy of decolonization regimens. We prospectively evaluated 31 patients with recurrent CA-MRSA skin infections who received nasal mupirocin, topical hexachlorophene body wash, and an oral anti-MRSA antibiotic. The mean number of MRSA infections after the intervention decreased significantly from baseline (0.03 versus 0.84 infections/month, P = <0.0001). This regimen appears promising at preventing recurrent CA-MRSA infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom